RNA Aptamer Blockade of Osteopontin Inhibits Growth and Metastasis of MDA-MB231 Breast Cancer Cells
Open Access
- 1 January 2009
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 17 (1), 153-161
- https://doi.org/10.1038/mt.2008.235
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Osteopontin overexpression in breast cancer: Knowledge gained and possible implications for clinical managementJournal of Cellular Biochemistry, 2007
- The G12 family of heterotrimeric G proteins promotes breast cancer invasion and metastasisProceedings of the National Academy of Sciences, 2006
- Matrix metalloproteinases and tumor metastasisCancer and Metastasis Reviews, 2006
- Validating matrix metalloproteinases as drug targets and anti-targets for cancer therapyNature Reviews Cancer, 2006
- Osteopontin: role in cell signaling and cancer progressionTrends in Cell Biology, 2006
- Osteopontin: It's Role in Regulation of Cell Motility and Nuclear Factor κB-mediated Urokinase Type Plasminogen Activator ExpressionIUBMB Life, 2005
- Three small integrin‐binding ligand N‐linked glycoproteins (SIBLINGs) bind and activate specific matrix metalloproteinasesThe FASEB Journal, 2004
- Osteopontin Induces Nuclear Factor κB-mediated Promatrix Metalloproteinase-2 Activation through IκBα/IKK Signaling Pathways, and Curcumin (Diferulolylmethane) Down-regulates These PathwaysJournal of Biological Chemistry, 2003
- Isolation of a nuclease-resistant decoy RNA that selectively blocks autoantibody binding to insulin receptors on human lymphocytes.The Journal of Experimental Medicine, 1996
- Overcoming obstacles to metastasis ‐ defenses against host defenses: Osteopontin (OPN) as a shield against attack by cytotoxic host cellsJournal of Cellular Biochemistry, 1994